Communiqués Omnicell, Inc.

Actions

OMCL

US68213N1090

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
45,87 ^USD	-2,40%		+2,11%	+1,26%

01/07	Omnicell, Inc. annonce des changements au sein de sa direction	CI
01/07	Omnicell nomme Nnamdi Njoku au poste de président	MT

Communiqués

13/07	Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026	BU
01/07	Nnamdi Njoku Appointed President of Omnicell	BU
08/06	Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business	BU
02/06	Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026	BU
04/05	Omnicell to Present at the BofA Securities 2026 Healthcare Conference	BU
29/04	Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer	BU
28/04	Omnicell : Investor Presentation	PU
28/04	Omnicell: Q1 Earnings Snapshot	AQ
28/04	Omnicell Announces First Quarter 2026 Financial Results	BU
13/04	Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026	BU
05/02	Omnicell : Investor Presentation	PU
05/02	Omnicell: Q4 Earnings Snapshot	AQ
05/02	Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results	BU
13/01	Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026	BU
08/12	Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management	BU
01/12	Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show	BU
20/11	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference	BU
13/11	Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies	BU
30/10/25	Omnicell : Investor Presentation – October 2025	PU
30/10/25	Omnicell: Q3 Earnings Snapshot	AQ
30/10/25	Omnicell Announces Third Quarter 2025 Financial Results	BU
07/10/25	Omnicell to Release Third Quarter 2025 Financial Results on October 30 2025	AQ
06/10/25	Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025	BU
27/08/25	Evoke Pharma and EVERSANA Expand GIMOTI Access to Gastro Health and Other Large GI Practices through Omnicell Relationship	AQ
26/08/25	Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship	AQ